Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
A Phase II Study of Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Sponsor: University of Miami
Terminated
Investigator Decision - Insufficient Accrual
Other terminated trials from University of Miami
Other Bladder Cancer trials with similar outcome
This NA trial investigates Bladder Cancer and Bladder Carcinoma and is currently terminated or withdrawn. University of Miami leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Sep 2018 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 4 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Miami
For direct contact, visit the study record on ClinicalTrials.gov .